AST SpaceMobile reports tonight with its structural short position essentially unchanged — and a borrow market that has opened just enough to matter, but not enough to defuse the tension.
The positioning story enters the print in broadly the same shape as prior notes described, with one meaningful update: availability has held at 13.0%, the most open the lending pool has been since mid-July, after weeks of near-zero readings that peaked at a 52-week low of 0.31% on July 24. That is still tight by any normal standard — roughly one share available for every eight already borrowed — but it is meaningfully different from the frozen conditions that dominated late July. Short interest itself has not moved in response. At 63.2 million shares, or 22.8% of free float, the position is essentially flat on the week and down only fractionally from the 70 million shares held at the start of July. Bears have not covered; the extra supply entering the pool is new inventory, not capitulation. Cost to borrow has ticked back to 1.30%, still 25% above where it was a month ago. The ORTEX short score holds at 70.2, ranking in the bottom 3rd percentile of the universe. Options traders are not adding a strong directional signal — the put/call ratio at 0.46 is virtually in line with its 20-day average and the z-score is near zero.
The core debate is whether ASTS can demonstrate progress toward a commercially viable constellation fast enough to justify a valuation that remains deeply stretched. Bulls point to the direct-to-device patent portfolio, international MNO agreements, and the thesis that a superior 5G satellite service creates a defensible moat. Piper Sandler initiated with an Overweight rating and a $100 target in mid-July; B. Riley upgraded to Buy with an $85 target shortly after. Bears, including Barclays which holds an Underweight with a $65 target, argue the capital-intensive model, reliance on third-party launchers, and Starlink's head start make the commercialization timeline deeply uncertain. Deutsche Bank's downgrade to Hold in late May — cutting its target from $117 to $106 — is a useful marker: the Street's patience with execution risk has limits even among prior believers. The consensus sits at Hold, with a mean target of $80.48 against a current price of $68.76, implying modest upside that belies the wide dispersion of views.
Insider activity adds a cautionary note. The CEO sold 2.5 million shares at $58.68 in late June — a $146.7 million transaction — while the CFO, CTO, COO, and President have all sold stock in recent months. The 90-day net value sold totals roughly $447 million. These are large, concentrated disposals from the people closest to the execution risk.
History offers a sobering data point on reaction risk. The June 12 print produced a 10% single-day drop and a 25% drawdown over the following five trading sessions. The May 11 print saw a 3% one-day dip before recovering 16% over five days. The range of outcomes is wide, and the short base — still over a fifth of the float — means any catalyst in either direction carries amplified consequences. Tonight's print is less about near-term revenue figures and more about what management says on constellation deployment pace, MNO conversion timelines, and the capital plan — the variables that have consistently separated bulls from bears in this name.
See the live data behind this article on ORTEX.
Open ASTS on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
